Showing results (141-150 of 180) with videos related to
Sort By:
Pageof 18
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 25, 2025
Drug DevelopmentChe-Yuan Wu, Abhinav Sharma, Jodi D Edwards, et al.Journal of the American College of Cardiology|May 14, 2011
The primary benefits of angiotensin-converting enzyme inhibition on cardiac remodeling occur during sleep time in murine pressure overload hypertrophyTami A Martino, Nazneen Tata, Jeremy A Simpson, et al.Circulation. Arrhythmia and Electrophysiology|July 13, 2011
Iron overload decreases CaV1.3-dependent L-type Ca2+ currents leading to bradycardia, altered electrical conduction, and atrial fibrillationRobert A Rose, Michael Sellan, Jeremy A Simpson, et al.Journal of the American Heart Association|October 22, 2014
Endoplasmic reticulum resident protein 44 (ERp44) deficiency in mice and zebrafish leads to cardiac developmental and functional defectsDing-Yan Wang, Cynthia Abbasi, Suzan El-Rass, et al.Circulation|September 23, 2009
Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cellsYuichiro Maekawa, Nobuo Mizue, Annie Chan, et al.Nature Communications|March 12, 2014
HACE1-dependent protein degradation provides cardiac protection in response to haemodynamic stressLiyong Zhang, Xin Chen, Parveen Sharma, et al.CMAJ Open|August 23, 2022
Trends in glucose testing among individuals without diabetes in Ontario between 2010 and 2017: a population-based cohort studyAnna Chu, Baiju R Shah, Mohammed Rashid, et al.Hypertension (Dallas, Tex. : 1979)|January 8, 2014
Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophyDing-Sheng Jiang, Yu Liu, Heng Zhou, et al.The Journal of Thoracic and Cardiovascular Surgery|December 17, 2013
Clinical, biochemical, and genetic predictors of coronary artery bypass graft failureBobby Yanagawa, Khaled D Algarni, Steve K Singh, et al.Basic Research in Cardiology|January 12, 2013
Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophyJing Lu, Zhou-Yan Bian, Ran Zhang, et al.Pageof 18